Disclosures for "PRAX-562-101: A Phase 1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of PRAX-562 in Healthy Volunteers")
-
-
Dr. Mahalingam has nothing to disclose.
-
Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Patel has received personal compensation for serving as an employee of Praxis Precision Medicines, Inc.. Dr. Patel has received personal compensation for serving as an employee of Noven Pharmaceuticals. Dr. Patel has stock in Praxis Precision Medicines, Inc..
-
Dr. Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Jacotin has received personal compensation for serving as an employee of Takeda. Dr. Jacotin has stock in Takeda. Dr. Jacotin has stock in Certara. Dr. Jacotin has stock in Clover Health. Dr. Jacotin has stock in Coinbase.
-
Marjie Hard has nothing to disclose.
-
-
Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.
-
-
Steven Petrou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Steven Petrou has stock in Praxis Precision Medicines. The institution of Steven Petrou has received research support from Praxis Precision Medicines. The institution of Steven Petrou has received research support from Medical Research Future Fund. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care.